1、降息预期增厚,哪些公司会受益?
2、$Cellectar(CLRB)$ 数据发布在即,是否有交易机会?
3、 $AC Immune(ACIU)$ 与武田合作,是否有配置机会?查看全文
产业链观察05-13 18:24
#药闻简讯# $AC Immune(ACIU)$ 与武田签署针对阿尔茨海默病β淀粉样蛋白的主动免疫疗法的独家选择权和许可协议。
AC Immune将获得$100M的预付款。查看全文
AC Immune(ACIU)05-21 20:05
$AC Immune(ACIU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0000950103-24-006931 Act: 34 Size: 33 MB 网页链接查看全文
AC Immune(ACIU)05-13 18:05
$AC Immune(ACIU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0000950103-24-006573 Act: 34 Size: 63 KB 网页链接查看全文
AC Immune(ACIU)07-25 20:05
$AC Immune(ACIU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0000950103-24-010718 Act: 34 Size: 102 KB 网页链接查看全文
AC Immune(ACIU)05-17 02:25
$AC Immune(ACIU)$ 144 Report of proposed sale of securities Accession Number: 0001965301-24-000070 Act: 33 Size: 4 KB 网页链接查看全文
AC Immune(ACIU)05-13 18:25
$AC Immune(ACIU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001558370-24-007857 Act: 34 Size: 912 KB 网页链接查看全文
AC Immune(ACIU)06-21 04:45
$AC Immune(ACIU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0000950103-24-008566 Act: 34 Size: 12 MB 网页链接查看全文
取名真烦2016-12-12 23:13
$AC Immune SA Common Stock(ACIU)$ 还是不太看好Crenezumab,目前为止A-beta这个靶点上除了biogen全部都是失败,真的是偶然吗查看全文
在美国FDA批准了Biogen公司的阿尔茨海默病药物Aduhelm后,周一收盘该公司股价飙涨38%,股价逼近400美元,创下六年多来的最高水平,市值增加超过160亿美元。 受此影响,美国开发阿尔茨海默病疗法的公司股价也都大幅上涨,礼来股价大涨10%,AC Immune公司... 网页链接
$AC Immune(ACIU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0000950103-24-010718 Act: 34 Size: 102 KB 网页链接
$AC Immune(ACIU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0000950103-24-008566 Act: 34 Size: 12 MB 网页链接
$AC Immune(ACIU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0000950103-24-006931 Act: 34 Size: 33 MB 网页链接
$AC Immune(ACIU)$ 144 Report of proposed sale of securities Accession Number: 0001965301-24-000070 Act: 33 Size: 4 KB 网页链接
$AC Immune(ACIU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001558370-24-007857 Act: 34 Size: 912 KB 网页链接
$AC Immune(ACIU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0000950103-24-006573 Act: 34 Size: 63 KB 网页链接
$AC Immune(ACIU)$ F-3 Registration statement by foreign private issuers Accession Number: 0000950103-24-003853 Act: 33 Size: 1 MB 网页链接
$AC Immune(ACIU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-24-034238 Act: 34 Size: 4 MB 网页链接
$AC Immune(ACIU)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001558370-24-003164 Act: 34 Size: 20 MB 网页链接
$AC Immune(ACIU)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001214659-24-002252 Act: 34 Size: 38 KB 网页链接